By
TB Vax ARM
Published: March 22, 2024, 9:30 p.m.·
Tags:
Vaccines,
Research and development,
Access,
Advocacy
The TB Vax ARM outlines three key advocacy wins for the field to achieve by 2026 in order to effectively advance TB vaccine development. Check them out and sign a petition to show your support!
Read More →
By
ill & Melinda Gates Medical Research Institute
Published: March 19, 2024, 3:45 p.m.·
Tags:
Vaccines,
Research and development
-- A large Phase 3 trial will evaluate whether the M72/AS01E vaccine candidate can protect adolescents and adults from pulmonary tuberculosis
-- Clinical trial site at University of the Witwatersrand, Johannesburg, South Africa, is first of up to 60 sites in seven countries
-- The M72/AS01E vaccine candidate could be the first new TB vaccine in 100 years if proven effective
Read More →
By
WGNV
Published: Feb. 19, 2024, 3:16 p.m.·
Tags:
Vaccines,
Research and development,
Advocacy
The Stop TB Partnership Working Group on New TB Vaccines (WGNV) released a newsletter with the latest updates related to TB vaccines.
Read More →
By
Xinhua
Published: Dec. 11, 2023, 8:21 p.m.·
Tags:
Global TB response,
Research and development
JOHANNESBURG, Dec. 11 (Xinhua) -- The BRICS Tuberculosis Research Network Innovation Summit kicked off on Monday in Durban, South Africa's coastal city, with scientists and senior officials from BRICS countries gathering together to facilitate collaborative research on innovations in tuberculosis diagnostics, vaccines, therapeutics and drugs and health systems strengthening.
Read More →
By
Treatment Action Group,
Stop TB Partnership
Published: Dec. 5, 2023, 8:29 p.m.·
Tags:
Global TB response,
Research and development,
Advocacy
TB research and development funding perilously off track of UN commitments to end TB by 2030.
Read More →
By
Global Health Advocates
Published: Oct. 26, 2023, 10:21 p.m.·
Tags:
Global TB response,
Research and development,
Advocacy
A call to action ahead of the Union Conference urges France to confirm the commitments made in the UN Political Declaration on TB and to translate it into concrete measures.
Read More →
By
Gavi
Published: Oct. 24, 2023, 8:28 p.m.·
Tags:
Vaccines,
Research and development
Efforts to fight the world’s biggest infectious killer are about to get a boost, with new vaccines on the horizon.
Read More →
By
University of Montana
Published: Oct. 23, 2023, 7:35 p.m.·
Tags:
Vaccines,
Research and development
MISSOULA, 23 October 2023 – The National Institutes of Health recently awarded a $12.3 million contract to the University of Montana to develop a novel vaccine adjuvant for use in a tuberculosis vaccine. Adjuvants are substances that boost the effectiveness of vaccines.
Read More →
By
TB Vax ARM
Published: Oct. 22, 2023, 8:56 p.m.·
Tags:
Vaccines,
Research and development
In preparation for the Union World Conference on Lung Health in Paris, France on 15-18 November 2023, the TB Vaccine Advocacy Roadmap (TB Vax ARM) will host a virtual meeting on 2 November 2023 exploring what’s next for TB research and development (R&D) following the United Nations High-Level Meeting on TB (HLM).
Read More →
By
Treatment Action Group
Published: Oct. 10, 2023, 7:24 p.m.·
Tags:
Vaccines,
Research and development
Treatment Action Group launches the first TB chapter of its 2023 Pipeline Report.
Read More →
Page 1 of 27 · Total posts: 10
1
2
Last→